Skip to main content
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

ChromaDex Corporation - Common Stock (NQ:CDXC)

7.870 UNCHANGED
Last Price Updated: 4:00 PM EDT, Mar 18, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about ChromaDex Corporation - Common Stock

< Previous 1 2 3 4 5 6 7 Next >
EXCLUSIVE: Chromadex CEO To Ring Nasdaq Closing Bell, Talks Walmart Product Launch
Chromadex Corp (NASDAQ: CDXC) is participating in the Nasdaq’s closing bell ceremony on Thursday afternoon to celebrate its five-year anniversary of trading on the exchange... 
Via Benzinga
The Promise Of Longevity Science: 3 Small-Cap Companies With Anti-Aging Products
The challenge in securing a longer and healthier life was the focus of “Investing in Longevity Science: The New Drugs & Therapies Designed to Prolong Your Lifespan,... 
Via Benzinga
10 Biggest Price Target Changes For Monday
BMO Capital boosted The Middleby Corporation (NASDAQ: MIDD) price target from $225 to $250. Middleby shares rose 1.9% to close at $182.83 on Friday. Atlantic Equities reduced... 
Via Benzinga
ChromaDex Corporation (CDXC) Q1 2021 Earnings Call Transcript
CDXC earnings call for the period ending March 31, 2021. 
Via The Motley Fool
Topics Earnings
12 Health Care Stocks Moving In Friday's Intraday Session
Gainers Yield10 Bioscience (NASDAQ:YTEN) stock increased by 20.74% to $10.36 during Friday's regular session. As of 12:30 EST, Yield10 Bioscience's stock is... 
Via Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
Gainers T2 Biosystems (NASDAQ:TTOO) share... 
Via Benzinga
ChromaDex Corporation Reports First Quarter 2021 Financial Results
From ChromaDex Corporation
Via Business Wire
ChromaDex and Ro Partner for New Product Development
From ChromaDex Corporation
Via Business Wire
ChromaDex to Present at Benzinga’s Global Small Cap Conference on May 13, 2021
From ChromaDex Corporation
Via Business Wire
ChromaDex to Report First Quarter 2021 Financial Results on Thursday, May 6, 2021
From ChromaDex Corporation
Via Business Wire
ChromaDex and Health & Happiness (H&H) Group Announce Supply Agreement for Niagen®
From ChromaDex Corporation
Via Business Wire
ChromaDex Appoints Fadi Karam as Chief Marketing Officer
From ChromaDex Corporation
Via Business Wire
< Previous 1 2 3 4 5 6 7 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.